Screening (for) - in the ICD-10-CM Index
Annotation Back-References in the 2025 ICD-10-CM Index to Diseases and Injuries
Browse the ICD-10-CM codes with references applicable to the clinical term "screening (for)"
Screening (for) - Z13.9 Encounter for screening, unspecified
alcoholism - Z13.39 Encounter for screening examination for other mental health and behavioral disorders
anemia - Z13.0 Encounter for screening for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
anomaly, congenital - Z13.89 Encounter for screening for other disorder
antenatal, of mother - See Also: Encounter, antenatal screening; - Z36.9 Encounter for antenatal screening, unspecified
arterial hypertension - Z13.6 Encounter for screening for cardiovascular disorders
autism - Z13.41 Encounter for autism screening
bacteriuria, asymptomatic - Z13.89 Encounter for screening for other disorder
behavioral disorder - Z13.30 Encounter for screening examination for mental health and behavioral disorders, unspecified
specified NEC - Z13.39 Encounter for screening examination for other mental health and behavioral disorders
brain injury, traumatic - Z13.850 Encounter for screening for traumatic brain injury
bronchitis, chronic - Z13.83 Encounter for screening for respiratory disorder NEC
brucellosis - Z11.2 Encounter for screening for other bacterial diseases
cardiovascular disorder - Z13.6 Encounter for screening for cardiovascular disorders
cataract - Z13.5 Encounter for screening for eye and ear disorders
chlamydial diseases - Z11.8 Encounter for screening for other infectious and parasitic diseases
cholera - Z11.0 Encounter for screening for intestinal infectious diseases
chromosomal abnormalities (nonprocreative) NEC - Z13.79 Encounter for other screening for genetic and chromosomal anomalies
colonoscopy - Z12.11 Encounter for screening for malignant neoplasm of colon
congenital
contamination NEC - Z13.88 Encounter for screening for disorder due to exposure to contaminants
COVID-19 - Z11.52 Encounter for screening for COVID-19
cystic fibrosis - Z13.228 Encounter for screening for other metabolic disorders
dengue fever - Z11.59 Encounter for screening for other viral diseases
dental disorder - Z13.84 Encounter for screening for dental disorders
depression (adult) (adolescent) (child) - Z13.31 Encounter for screening for depression
developmental
diabetes mellitus - Z13.1 Encounter for screening for diabetes mellitus
diphtheria - Z11.2 Encounter for screening for other bacterial diseases
disability, intellectual - Z13.39 Encounter for screening examination for other mental health and behavioral disorders
disease or disorder - Z13.9 Encounter for screening, unspecified
bacterial NEC - Z11.2 Encounter for screening for other bacterial diseases
behavioral - Z13.30 Encounter for screening examination for mental health and behavioral disorders, unspecified
specified NEC - Z13.39 Encounter for screening examination for other mental health and behavioral disorders
blood or blood-forming organ - Z13.0 Encounter for screening for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
cardiovascular - Z13.6 Encounter for screening for cardiovascular disorders
Chagas' - Z11.6 Encounter for screening for other protozoal diseases and helminthiases
chlamydial - Z11.8 Encounter for screening for other infectious and parasitic diseases
COVID-19 - Z11.52 Encounter for screening for COVID-19
dental - Z13.89 Encounter for screening for other disorder
developmental delays - Z13.40 Encounter for screening for unspecified developmental delays
digestive tract NEC - Z13.818 Encounter for screening for other digestive system disorders
ear - Z13.5 Encounter for screening for eye and ear disorders
endocrine - Z13.29 Encounter for screening for other suspected endocrine disorder
eye - Z13.5 Encounter for screening for eye and ear disorders
genitourinary - Z13.89 Encounter for screening for other disorder
heart - Z13.6 Encounter for screening for cardiovascular disorders
human immunodeficiency virus (HIV) infection - Z11.4 Encounter for screening for human immunodeficiency virus [HIV]
immunity - Z13.0 Encounter for screening for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
infection
infectious - Z11.9 Encounter for screening for infectious and parasitic diseases, unspecified
mental health and behavioral - Z13.30 Encounter for screening examination for mental health and behavioral disorders, unspecified
specified NEC - Z13.39 Encounter for screening examination for other mental health and behavioral disorders
metabolic - Z13.228 Encounter for screening for other metabolic disorders
neurological - Z13.89 Encounter for screening for other disorder
nutritional - Z13.21 Encounter for screening for nutritional disorder
protozoal - Z11.6 Encounter for screening for other protozoal diseases and helminthiases
intestinal - Z11.0 Encounter for screening for intestinal infectious diseases
respiratory - Z13.83 Encounter for screening for respiratory disorder NEC
rheumatic - Z13.828 Encounter for screening for other musculoskeletal disorder
rickettsial - Z11.8 Encounter for screening for other infectious and parasitic diseases
sexually-transmitted NEC - Z11.3 Encounter for screening for infections with a predominantly sexual mode of transmission
human immunodeficiency virus (HIV) - Z11.4 Encounter for screening for human immunodeficiency virus [HIV]
sickle-cell (trait) - Z13.0 Encounter for screening for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
skin - Z13.89 Encounter for screening for other disorder
specified NEC - Z13.89 Encounter for screening for other disorder
spirochetal - Z11.8 Encounter for screening for other infectious and parasitic diseases
thyroid - Z13.29 Encounter for screening for other suspected endocrine disorder
vascular - Z13.6 Encounter for screening for cardiovascular disorders
venereal - Z11.3 Encounter for screening for infections with a predominantly sexual mode of transmission
elevated titer - Z13.89 Encounter for screening for other disorder
emphysema - Z13.83 Encounter for screening for respiratory disorder NEC
exposure to contaminants (toxic) - Z13.88 Encounter for screening for disorder due to exposure to contaminants
fever
filariasis - Z11.6 Encounter for screening for other protozoal diseases and helminthiases
galactosemia - Z13.228 Encounter for screening for other metabolic disorders
gastrointestinal condition - Z13.818 Encounter for screening for other digestive system disorders
genetic (nonprocreative) - for procreative management - See: Testing, genetic, for procreative management;
genitourinary condition - Z13.89 Encounter for screening for other disorder
glaucoma - Z13.5 Encounter for screening for eye and ear disorders
gonorrhea - Z11.3 Encounter for screening for infections with a predominantly sexual mode of transmission
gout - Z13.89 Encounter for screening for other disorder
helminthiasis (intestinal) - Z11.6 Encounter for screening for other protozoal diseases and helminthiases
hematopoietic malignancy - Z12.89 Encounter for screening for malignant neoplasm of other sites
hemoglobinopathies NEC - Z13.0 Encounter for screening for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
hemorrhagic fever - Z11.59 Encounter for screening for other viral diseases
Hodgkin disease - Z12.89 Encounter for screening for malignant neoplasm of other sites
human immunodeficiency virus (HIV) - Z11.4 Encounter for screening for human immunodeficiency virus [HIV]
human papillomavirus - Z11.51 Encounter for screening for human papillomavirus (HPV)
hypertension - Z13.6 Encounter for screening for cardiovascular disorders
immunity disorders - Z13.0 Encounter for screening for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
infant or child (over 28 days old) - Z00.129 Encounter for routine child health examination without abnormal findings
with abnormal findings - Z00.121 Encounter for routine child health examination with abnormal findings
infection
ingestion of radioactive substance - Z13.88 Encounter for screening for disorder due to exposure to contaminants
intellectual disability - Z13.39 Encounter for screening examination for other mental health and behavioral disorders
intestinal
leishmaniasis - Z11.6 Encounter for screening for other protozoal diseases and helminthiases
leprosy - Z11.2 Encounter for screening for other bacterial diseases
leptospirosis - Z11.8 Encounter for screening for other infectious and parasitic diseases
leukemia - Z12.89 Encounter for screening for malignant neoplasm of other sites
lymphoma - Z12.89 Encounter for screening for malignant neoplasm of other sites
malaria - Z11.6 Encounter for screening for other protozoal diseases and helminthiases
malnutrition - Z13.29 Encounter for screening for other suspected endocrine disorder
measles - Z11.59 Encounter for screening for other viral diseases
mental health disorder - Z13.30 Encounter for screening examination for mental health and behavioral disorders, unspecified
specified NEC - Z13.39 Encounter for screening examination for other mental health and behavioral disorders
metabolic errors, inborn - Z13.228 Encounter for screening for other metabolic disorders
multiphasic - Z13.89 Encounter for screening for other disorder
musculoskeletal disorder - Z13.828 Encounter for screening for other musculoskeletal disorder
osteoporosis - Z13.820 Encounter for screening for osteoporosis
mycoses - Z11.8 Encounter for screening for other infectious and parasitic diseases
myocardial infarction (acute) - Z13.6 Encounter for screening for cardiovascular disorders
neoplasm (malignant) (of) - Z12.9 Encounter for screening for malignant neoplasm, site unspecified
bladder - Z12.6 Encounter for screening for malignant neoplasm of bladder
blood - Z12.89 Encounter for screening for malignant neoplasm of other sites
breast - Z12.39 Encounter for other screening for malignant neoplasm of breast
routine mammogram - Z12.31 Encounter for screening mammogram for malignant neoplasm of breast
cervix - Z12.4 Encounter for screening for malignant neoplasm of cervix
colon - Z12.11 Encounter for screening for malignant neoplasm of colon
genitourinary organs NEC - Z12.79 Encounter for screening for malignant neoplasm of other genitourinary organs
bladder - Z12.6 Encounter for screening for malignant neoplasm of bladder
cervix - Z12.4 Encounter for screening for malignant neoplasm of cervix
ovary - Z12.73 Encounter for screening for malignant neoplasm of ovary
prostate - Z12.5 Encounter for screening for malignant neoplasm of prostate
testis - Z12.71 Encounter for screening for malignant neoplasm of testis
vagina - Z12.72 Encounter for screening for malignant neoplasm of vagina
hematopoietic system - Z12.89 Encounter for screening for malignant neoplasm of other sites
intestinal tract - Z12.10 Encounter for screening for malignant neoplasm of intestinal tract, unspecified
lung - Z12.2 Encounter for screening for malignant neoplasm of respiratory organs
lymph (glands) - Z12.89 Encounter for screening for malignant neoplasm of other sites
nervous system - Z12.82 Encounter for screening for malignant neoplasm of nervous system
oral cavity - Z12.81 Encounter for screening for malignant neoplasm of oral cavity
prostate - Z12.5 Encounter for screening for malignant neoplasm of prostate
rectum - Z12.12 Encounter for screening for malignant neoplasm of rectum
respiratory organs - Z12.2 Encounter for screening for malignant neoplasm of respiratory organs
skin - Z12.83 Encounter for screening for malignant neoplasm of skin
small intestine - Z12.13 Encounter for screening for malignant neoplasm of small intestine
specified site NEC - Z12.89 Encounter for screening for malignant neoplasm of other sites
stomach - Z12.0 Encounter for screening for malignant neoplasm of stomach
nephropathy - Z13.89 Encounter for screening for other disorder
nervous system disorders NEC - Z13.858 Encounter for screening for other nervous system disorders
neurological condition - Z13.89 Encounter for screening for other disorder
osteoporosis - Z13.820 Encounter for screening for osteoporosis
parasitic infestation - Z11.9 Encounter for screening for infectious and parasitic diseases, unspecified
specified NEC - Z11.8 Encounter for screening for other infectious and parasitic diseases
phenylketonuria - Z13.228 Encounter for screening for other metabolic disorders
plague - Z11.2 Encounter for screening for other bacterial diseases
poisoning (chemical) (heavy metal) - Z13.88 Encounter for screening for disorder due to exposure to contaminants
poliomyelitis - Z11.59 Encounter for screening for other viral diseases
postnatal, chromosomal abnormalities - Z13.89 Encounter for screening for other disorder
prenatal, of mother - See Also: Encounter, antenatal screening; - Z36.9 Encounter for antenatal screening, unspecified
protozoal disease - Z11.6 Encounter for screening for other protozoal diseases and helminthiases
intestinal - Z11.0 Encounter for screening for intestinal infectious diseases
pulmonary tuberculosis - Z11.1 Encounter for screening for respiratory tuberculosis
radiation exposure - Z13.88 Encounter for screening for disorder due to exposure to contaminants
respiratory condition - Z13.83 Encounter for screening for respiratory disorder NEC
respiratory tuberculosis - Z11.1 Encounter for screening for respiratory tuberculosis
rheumatoid arthritis - Z13.828 Encounter for screening for other musculoskeletal disorder
rubella - Z11.59 Encounter for screening for other viral diseases
SARS-CoV-2 - Z11.52 Encounter for screening for COVID-19
schistosomiasis - Z11.6 Encounter for screening for other protozoal diseases and helminthiases
sexually-transmitted disease NEC - Z11.3 Encounter for screening for infections with a predominantly sexual mode of transmission
human immunodeficiency virus (HIV) - Z11.4 Encounter for screening for human immunodeficiency virus [HIV]
sickle-cell disease or trait - Z13.0 Encounter for screening for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
skin condition - Z13.89 Encounter for screening for other disorder
sleeping sickness - Z11.6 Encounter for screening for other protozoal diseases and helminthiases
special - Z13.9 Encounter for screening, unspecified
specified NEC - Z13.89 Encounter for screening for other disorder
syphilis - Z11.3 Encounter for screening for infections with a predominantly sexual mode of transmission
tetanus - Z11.2 Encounter for screening for other bacterial diseases
trachoma - Z11.8 Encounter for screening for other infectious and parasitic diseases
traumatic brain injury - Z13.850 Encounter for screening for traumatic brain injury
trypanosomiasis - Z11.6 Encounter for screening for other protozoal diseases and helminthiases
tuberculosis, respiratory - Z11.1 Encounter for screening for respiratory tuberculosis
venereal disease - Z11.3 Encounter for screening for infections with a predominantly sexual mode of transmission
whooping cough - Z11.2 Encounter for screening for other bacterial diseases
worms, intestinal - Z11.6 Encounter for screening for other protozoal diseases and helminthiases
yaws - Z11.8 Encounter for screening for other infectious and parasitic diseases
yellow fever - Z11.59 Encounter for screening for other viral diseases
Applicable Clinical Terms Definitions
Alcoholism: A primary, chronic disease with genetic, psychosocial, and environmental factors influencing its development and manifestations. The disease is often progressive and fatal. It is characterized by impaired control over drinking, preoccupation with the drug alcohol, use of alcohol despite adverse consequences, and distortions in thinking, most notably denial. Each of these symptoms may be continuous or periodic. (Morse & Flavin for the Joint Commission of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism: in JAMA 1992;268:1012-4)
Anemia: A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.
Autistic Disorder: A disorder beginning in childhood. It is marked by the presence of markedly abnormal or impaired development in social interaction and communication and a markedly restricted repertoire of activity and interest. Manifestations of the disorder vary greatly depending on the developmental level and chronological age of the individual. (DSM-V)
Brucellosis: Infection caused by bacteria of the genus BRUCELLA mainly involving the MONONUCLEAR PHAGOCYTE SYSTEM. This condition is characterized by fever, weakness, malaise, and weight loss.
Cataract: Partial or complete opacity on or in the lens or capsule of one or both eyes, impairing vision or causing blindness. The many kinds of cataract are classified by their morphology (size, shape, location) or etiology (cause and time of occurrence). (Dorland, 27th ed)
Cholera: An acute diarrheal disease endemic in India and Southeast Asia whose causative agent is VIBRIO CHOLERAE. This condition can lead to severe dehydration in a matter of hours unless quickly treated.
Colonoscopy: Endoscopic examination, therapy or surgery of the luminal surface of the colon.
COVID-19: A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent.
Cystic Fibrosis: An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
Diphtheria: A localized infection of mucous membranes or skin caused by toxigenic strains of CORYNEBACTERIUM DIPHTHERIAE. It is characterized by the presence of a pseudomembrane at the site of infection. DIPHTHERIA TOXIN, produced by C. diphtheriae, can cause myocarditis, polyneuritis, and other systemic toxic effects.
Emphysema: A pathological accumulation of air in tissues or organs.
Fever: An abnormal elevation of body temperature, usually as a result of a pathologic process.
Filariasis: Infections with nematodes of the superfamily FILARIOIDEA. The presence of living worms in the body is mainly asymptomatic but the death of adult worms leads to granulomatous inflammation and permanent fibrosis. Organisms of the genus Elaeophora infect wild elk and domestic sheep causing ischemic necrosis of the brain, blindness, and dermatosis of the face.
Galactosemias: A group of inherited enzyme deficiencies which feature elevations of GALACTOSE in the blood. This condition may be associated with deficiencies of GALACTOKINASE; UDPGLUCOSE-HEXOSE-1-PHOSPHATE URIDYLYLTRANSFERASE; or UDPGLUCOSE 4-EPIMERASE. The classic form is caused by UDPglucose-Hexose-1-Phosphate Uridylyltransferase deficiency, and presents in infancy with FAILURE TO THRIVE; VOMITING; and INTRACRANIAL HYPERTENSION. Affected individuals also may develop MENTAL RETARDATION; JAUNDICE; hepatosplenomegaly; ovarian failure (PRIMARY OVARIAN INSUFFICIENCY); and cataracts. (From Menkes, Textbook of Child Neurology, 5th ed, pp61-3)
Glaucoma: An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed)
Gonorrhea: Acute infectious disease characterized by primary invasion of the urogenital tract. The etiologic agent, NEISSERIA GONORRHOEAE, was isolated by Neisser in 1879.
Gout: Metabolic disorder characterized by recurrent acute arthritis, hyperuricemia and deposition of sodium urate in and around the joints, sometimes with formation of URIC ACID calculi.
Hodgkin Disease: A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.
Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.
Intellectual Disability: Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28)
Leishmaniasis: A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL).
Leprosy: A chronic granulomatous infection caused by MYCOBACTERIUM LEPRAE. The granulomatous lesions are manifested in the skin, the mucous membranes, and the peripheral nerves. Two polar or principal types are lepromatous and tuberculoid.
Leptospirosis: Infections with bacteria of the genus LEPTOSPIRA.
Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)
Lymphoma: A general term for various neoplastic diseases of the lymphoid tissue.
Malaria: A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia.
Malnutrition: An imbalanced nutritional status resulting from insufficient intake of nutrients to meet normal physiological requirement.
Measles: A highly contagious infectious disease caused by MORBILLIVIRUS, common among children but also seen in the nonimmune of any age, in which the virus enters the respiratory tract via droplet nuclei and multiplies in the epithelial cells, spreading throughout the MONONUCLEAR PHAGOCYTE SYSTEM.
Mycoses: Diseases caused by FUNGI.
Osteoporosis: Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.
Phenylketonurias: A group of autosomal recessive disorders marked by a deficiency of the hepatic enzyme PHENYLALANINE HYDROXYLASE or less frequently by reduced activity of DIHYDROPTERIDINE REDUCTASE (i.e., atypical phenylketonuria). Classical phenylketonuria is caused by a severe deficiency of phenylalanine hydroxylase and presents in infancy with developmental delay; SEIZURES; skin HYPOPIGMENTATION; ECZEMA; and demyelination in the central nervous system. (From Adams et al., Principles of Neurology, 6th ed, p952).
Plague: An acute infectious disease caused by YERSINIA PESTIS that affects humans, wild rodents, and their ectoparasites. This condition persists due to its firm entrenchment in sylvatic rodent-flea ecosystems throughout the world. Bubonic plague is the most common form.
Poliomyelitis: An acute infectious disease of humans, particularly children, caused by any of three serotypes of human poliovirus (POLIOVIRUS). Usually the infection is limited to the gastrointestinal tract and nasopharynx, and is often asymptomatic. The central nervous system, primarily the spinal cord, may be affected, leading to rapidly progressive paralysis, coarse FASCICULATION and hyporeflexia. Motor neurons are primarily affected. Encephalitis may also occur. The virus replicates in the nervous system, and may cause significant neuronal loss, most notably in the spinal cord. A rare related condition, nonpoliovirus poliomyelitis, may result from infections with nonpoliovirus enteroviruses. (From Adams et al., Principles of Neurology, 6th ed, pp764-5)
Rubella: An acute infectious disease caused by the RUBELLA VIRUS. The virus enters the respiratory tract via airborne droplet and spreads to the LYMPHATIC SYSTEM.
SARS-CoV-2: A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis.
Schistosomiasis: Infection with flukes (trematodes) of the genus SCHISTOSOMA. Three species produce the most frequent clinical diseases: SCHISTOSOMA HAEMATOBIUM (endemic in Africa and the Middle East), SCHISTOSOMA MANSONI (in Egypt, northern and southern Africa, some West Indies islands, northern 2/3 of South America), and SCHISTOSOMA JAPONICUM (in Japan, China, the Philippines, Celebes, Thailand, Laos). S. mansoni is often seen in Puerto Ricans living in the United States.
Syphilis: A contagious venereal disease caused by the spirochete TREPONEMA PALLIDUM.
Tetanus: A disease caused by tetanospasmin, a powerful protein toxin produced by CLOSTRIDIUM TETANI. Tetanus usually occurs after an acute injury, such as a puncture wound or laceration. Generalized tetanus, the most common form, is characterized by tetanic muscular contractions and hyperreflexia. Localized tetanus presents itself as a mild condition with manifestations restricted to muscles near the wound. It may progress to the generalized form.
Trachoma: A chronic infection of the CONJUNCTIVA and CORNEA caused by CHLAMYDIA TRACHOMATIS.
Trypanosomiasis: Infection with protozoa of the genus TRYPANOSOMA.
Sexually Transmitted Diseases: Diseases due to or propagated by sexual contact.
Whooping Cough: A respiratory infection caused by BORDETELLA PERTUSSIS and characterized by paroxysmal coughing ending in a prolonged crowing intake of breath.
Yaws: A systemic non-venereal infection of the tropics caused by TREPONEMA PALLIDUM subspecies pertenue.
Yellow Fever: An acute infectious disease primarily of the tropics, caused by a virus and transmitted to man by mosquitoes of the genera Aedes and Haemagogus. The severe form is characterized by fever, HEMOLYTIC JAUNDICE, and renal damage.
